The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Health Products & Services > Medical Instruments & Supplies > LXN Corporation

LXN Corporation
 PROFILE
LXN helps people with diabetes manage their disease. The company has developed FDA-approved GlucoProtein tests that allow patients with Type 2 diabetes to monitor their levels of blood glucose and glycated protein over a period of three weeks, rather than the customary three months; more frequent testing helps patients and their doctors analyze glucose control regimens and achieve better treatment. LXN's In Charge test is sold over the counter, while the Duet system is marketed to health care professionals for physician in-office testing. Johnson & Johnson is buying LXN as part of its purchase of the diabetes care division of Inverness Medical Technology (LXN's parent company).

 COMPETITION
Abbott Laboratories (ABT)
Bayer AG (BAYZY)
Roche Group (ROHHY)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 2.10
1-Yr. Sales Growth: (16.1)%
Employees: 53
Revenue per employee: $39,622.64

 KEY PEOPLE
• Michael A. Beeuwsaert
    CEO
• George Pache
    CFO

 CONTACT INFO
6325 Lusk Blvd.
San Diego, CA 92121
US
Phone: 858-546-7500
Fax: 858-320-4391
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001